Wayne B. Batchelor, MD, MHS, FSCAI | SCAI

Dr. Wayne Batchelor currently serves as the Director of Interventional Cardiology, Director of Interventional Cardiology Research, Innovation and Education, Associate Director of the Inova Heart and Vascular Institute in Fairfax, VA., and Adjunct Professor of Medicine at Duke University. He is experienced in complex percutaneous coronary interventions (PCI), radial artery PCI, transcatheter aortic valve replacement (TAVR), percutaneous mitral valve repair/replacement, percutaneous left atrial appendage closure, percutaneous ASD/PFO closure, percutaneous peripheral arterial revascularization, and carotid artery stenting. He has published over 120 peer-reviewed original abstracts/manuscripts, multiple book chapters and has participated in over 160 clinical trials, including being Principal Investigator in over 50. He was recently National Co-Principal Investigator of the PLATINUM DIVERSITY study, which was the first to prospectively evaluate clinical outcomes in minorities and women after coronary stent procedures in 52 sites across the US. Dr. Batchelor is the incoming Chair of the American College of Cardiology's (ACC) Interventional Sectional Leadership Council, serves on the Program Committee for the 2020 ACC/World Congress of Cardiology Scientific Sessions, the Scientific Program Committee of the Transcatheter Cardiovascular Therapeutics (TCT) Meeting and is President of the Duke University Cooperative Cardiovascular Society (DUCCS). He also serves on the NCDR STS/TVT Registry’s Steering Committee and on the newly formed Heart Valve Collaboratory, an academic consortium of stakeholders committed to advancing the eco-system of structural heart disease care. He has also been appointed as a special government employee/consultant to the U.S. Food and Drug Administration (FDA) within the Cardiovascular Devices Branch. In his spare time, Dr. Batchelor enjoys spending time with his wife, Zaneta, two daughters, Nadia and Samia, and 2 Miniature Schnauzers.